{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T19:09:14Z","timestamp":1719774554991},"reference-count":73,"publisher":"Oxford University Press (OUP)","issue":"suppl_5","license":[{"start":{"date-parts":[[2000,10,2]],"date-time":"2000-10-02T00:00:00Z","timestamp":970444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,10,2]]},"DOI":"10.1093\/ndt\/15.suppl_5.18","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:52:07Z","timestamp":1027723927000},"page":"18-24","source":"Crossref","is-referenced-by-count":13,"title":["Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites"],"prefix":"10.1093","volume":"15","author":[{"given":"Michael","family":"Sch\u00f6mig","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eberhard","family":"Ritz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2000,10,2]]},"reference":[{"key":"2021040806375890600_R1","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1681\/ASN.V10122465","article-title":"Expression of 25-hydroxyvitamin D3-1\u03b1-hydroxylase in the human kidney","volume":"10","author":"Zehnder","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"2021040806375890600_R2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000187089","article-title":"25-Hydroxyvitamin D3 metabolism in vitro by mononuclear cells from hemodialysis patients","volume":"62","author":"Reichel","year":"1992","journal-title":"Nephron"},{"key":"2021040806375890600_R3","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJM198410253111710","article-title":"Calcitriol, calcium, and granulomatous disease","volume":"311","author":"Lemann","year":"1984","journal-title":"New Engl J Med"},{"key":"2021040806375890600_R4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJM198108203050807","article-title":"Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D","volume":"305","author":"Barbour","year":"1981","journal-title":"New Engl J Med"},{"key":"2021040806375890600_R5","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1001\/archinte.1986.00360220089018","article-title":"Hypercalcemia and elevated calcitriol in a maintenance dialysis patient with tuberculosis","volume":"146","author":"Felsenfeld","year":"1986","journal-title":"Arch Intern Med"},{"key":"2021040806375890600_R6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/oxfordjournals.ndt.a027828","article-title":"Regulation of intestinal vitamin D receptor expression in experimental uraemia: effects of parathyroidectomy and administration of PTH","volume":"13","author":"Szabo","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"2021040806375890600_R7","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1172\/JCI116720","article-title":"Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients","volume":"92","author":"Fukuda","year":"1993","journal-title":"J Clin Invest"},{"key":"2021040806375890600_R8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1681\/ASN.V82271","article-title":"Secondary hyperparathyroidism and vitamin D receptor binding to vitamin D response elements in rats with incipient renal failure","volume":"8","author":"Sawaya","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"2021040806375890600_R9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00041552-199507000-00003","article-title":"Altered vitamin D metabolism and receptor interaction with the target genes in renal failure: calcitriol receptor interaction with its target gene in renal failure","volume":"4","author":"Hsu","year":"1995","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2021040806375890600_R10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1172\/JCI118061","article-title":"Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins","volume":"96","author":"Patel","year":"1995","journal-title":"J Clin Invest"},{"key":"2021040806375890600_R11","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1172\/JCI116720","article-title":"Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients","volume":"92","author":"Fukuda","year":"1993","journal-title":"J Clin Invest"},{"key":"2021040806375890600_R12","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ki.1997.41","article-title":"Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism","volume":"51","author":"Gogusev","year":"1997","journal-title":"Kidney Int"},{"key":"2021040806375890600_R13","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1681\/ASN.V9101845","article-title":"High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro","volume":"9","author":"Almaden","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"2021040806375890600_R14","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1172\/JCI118224","article-title":"Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D","volume":"96","author":"Naveh-Many","year":"1995","journal-title":"J Clin Invest"},{"key":"2021040806375890600_R15","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0005-2736(82)90202-4","article-title":"1\u03b1,25-Dihydroxy-vitamin D-3 regulates ATP-dependent calcium transport in basolateral plasma membranes of rat enterocytes","volume":"689","author":"Ghijsen","year":"1982","journal-title":"Biochim Biophys Acta"},{"key":"2021040806375890600_R16","first-page":"S135","article-title":"Skeletal response to intermittent calcitriol therapy in secondary hyperparathyroidism","volume":"53","author":"Salusky","year":"1996","journal-title":"Kidney Int Suppl"},{"key":"2021040806375890600_R17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF02556257","article-title":"1,25(OH)2D3 receptor regulation and 1,25(OH)2D3 effects in primary cultures of growth cartilage cells of the rat","volume":"49","author":"Klaus","year":"1991","journal-title":"Calcif Tissue Int"},{"key":"2021040806375890600_R18","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ki.1993.304","article-title":"Intermittent and continuous exposure to 1,25(OH)2D3 have different effects on growth plate chondrocytes in vitro","volume":"44","author":"Klaus","year":"1993","journal-title":"Kidney Int"},{"key":"2021040806375890600_R19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/01971528908053236","article-title":"Immunological evidences for the presence of small late carboxylterminal fragment (s) of human parathyroid hormone (PTH) in circulation in man","volume":"10","author":"D'Amour","year":"1989","journal-title":"J Immunoassay"},{"key":"2021040806375890600_R20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0009-8981(95)06171-1","article-title":"Immuno-chemiluminometric assay with two monoclonal antibodies against the N-terminal sequence of human parathyroid hormone","volume":"245","author":"Gao","year":"1996","journal-title":"Clin Chim Acta"},{"key":"2021040806375890600_R21","first-page":"A3165","article-title":"A novel mechanism for skeletal resistance in uremia","volume":"10","author":"Slatopolsky","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"2021040806375890600_R22","first-page":"1751","article-title":"Identification of risk factors on secondary hyperparathyroidism undergoing long-term haemodialysis with vitamin D3","volume":"9","author":"Mizumoto","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"2021040806375890600_R23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9343(92)90682-2","article-title":"Differences in vitamin D status between countries in young adults and the elderly","volume":"93","author":"McKenna","year":"1992","journal-title":"Am J Med"},{"key":"2021040806375890600_R24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(95)91266-5","article-title":"Serum vitamin D concentrations among elderly people in Europe","volume":"346","author":"Van der Wielen","year":"1995","journal-title":"Lancet"},{"key":"2021040806375890600_R25","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJM199803193381201","article-title":"Hypovitaminosis D in medical inpatients","volume":"338","author":"Thomas","year":"1998","journal-title":"New Engl J Med"},{"key":"2021040806375890600_R26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ndt\/12.1.16","article-title":"How important is vitamin D deficiency in uraemia?","volume":"12","author":"Cunningham","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"2021040806375890600_R27","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1172\/JCI108184","article-title":"25-Hydroxycholecalciferol stimulation of muscle metabolism","volume":"56","author":"Birge","year":"1975","journal-title":"J Clin Invest"},{"key":"2021040806375890600_R28","first-page":"499","article-title":"The effect of 25-hydroxy vitamin D3 in the osteomalacia of chronic renal failure","volume":"52","author":"Eastwood","year":"1977","journal-title":"Clin Sci Mol Med"},{"key":"2021040806375890600_R29","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2362.1973.tb02213.x","article-title":"Plasma 25-hydroxycholecalciferol in chronic renal failure","volume":"3","author":"Bayard","year":"1973","journal-title":"Eur J Clin Invest"},{"key":"2021040806375890600_R30","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1046\/j.1523-1755.1999.00480.x","article-title":"Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?","volume":"55","author":"Ghazali","year":"1999","journal-title":"Kidney Int"},{"key":"2021040806375890600_R31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ki.1979.25","article-title":"Comparison of 1ahydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization","volume":"15","author":"Fournier","year":"1979","journal-title":"Kidney Int"},{"key":"2021040806375890600_R32","first-page":"210","article-title":"Kinetics of serum 1,84 iPTH after high dose of calcitriol in uremic patients","volume":"39","author":"Seidel","year":"1993","journal-title":"Clin Nephrol"},{"key":"2021040806375890600_R33","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/ki.1993.377","article-title":"Intermittent versus continuous administration of 1,25-dihydroxyvitamin D3 in experimental renal hyperparathyroidism","volume":"44","author":"Reichel","year":"1993","journal-title":"Kidney Int"},{"key":"2021040806375890600_R34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1073-4449(12)80067-7","article-title":"Vitamin D therapy in patients receiving dialysis","volume":"2","author":"Ritz","year":"1995","journal-title":"Adv Ren Replace Ther"},{"key":"2021040806375890600_R35","first-page":"665","article-title":"Effect of the mode of calcitriol administration on PTH-ionized calcium relationship in uraemic patients with secondary hyperparathyroidism","volume":"10","author":"Caravaca","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"2021040806375890600_R36","first-page":"829","article-title":"\u2018Pulse\u2019 oral calcitriol in uraemic patients: rapid modification of parathyroid response to calcium","volume":"7","author":"Kwan","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"2021040806375890600_R37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000186210","article-title":"The \u2018oral 1,25-dihydroxyvitamin D3 pulse therapy\u2019 in hemodialysis patients with severe secondary hyperparathyroidism","volume":"57","author":"Tsukamoto","year":"1991","journal-title":"Nephron"},{"key":"2021040806375890600_R38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000168606","article-title":"Treatment of severe secondary hyperparathyroidism with administration of calcium carbonate, intermittent high oral doses of 1,25-dihydroxyvitamin D3 and dialysate with 3 mEq\/1 calcium concentration","volume":"13","author":"Perez-Mijares","year":"1993","journal-title":"Am J Nephrol"},{"key":"2021040806375890600_R39","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2169\/internalmedicine.32.695","article-title":"Suppression of secondary hyperparathyroidism in chronic dialysis patients by single oral weekly dose of 1,25-dihydroxycholecalciferol","volume":"32","author":"Shigematsu","year":"1993","journal-title":"Intern Med"},{"key":"2021040806375890600_R40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000187887","article-title":"Comparison of intermittent and continuous oral administration of calcitriol in dialysis patients: a randomized prospective trial","volume":"67","author":"Herrmann","year":"1994","journal-title":"Nephron"},{"key":"2021040806375890600_R41","article-title":"Daily but not pulse calcitriol therapy improves growth in experimental uremia","author":"Mehls","journal-title":"Pediatr Nephrol"},{"key":"2021040806375890600_R42","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI111639","article-title":"Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients","volume":"74","author":"Slatopolsky","year":"1984","journal-title":"J Clin Invest"},{"key":"2021040806375890600_R43","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ki.1992.404","article-title":"Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients. Italian Group for the Study of Intravenous Calcitriol","volume":"42","author":"Gallieni","year":"1992","journal-title":"Kidney Int"},{"key":"2021040806375890600_R44","first-page":"167","article-title":"Effective treatment of secondary hyperparathyroidism in hemodialysis patients by titration of intravenous calcitriol dosage","volume":"52","author":"Grekas","year":"1999","journal-title":"Clin Nephrol"},{"key":"2021040806375890600_R45","first-page":"216","article-title":"Comparison of intermittent oral and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism","volume":"40","author":"Fischer","year":"1993","journal-title":"Clin Nephrol"},{"key":"2021040806375890600_R46","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/ki.1994.223","article-title":"Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD","volume":"45","author":"Quarles","year":"1994","journal-title":"Kidney Int"},{"key":"2021040806375890600_R47","first-page":"599","article-title":"What stimuli control the activity of the parathyroid cell?","volume":"10","author":"Silver","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"2021040806375890600_R48","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.310.6976.358","article-title":"Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure","volume":"310","author":"Hamdy","year":"1995","journal-title":"Br Med J"},{"issue":"Suppl 3","key":"2021040806375890600_R49","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/ndt\/13.suppl_3.68","article-title":"Intermittent oral 1\u03b1-hydroxyvitamin D2 is effective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients. 1\u03b1D2 Study Group","volume":"13","author":"Frazao","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"2021040806375890600_R50","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1681\/ASN.V561344","article-title":"A comparison of oral and intravenous alphacalcidol in the treatment of uremic hyperparathyroidism","volume":"5","author":"Lee","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"2021040806375890600_R51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/ndt\/14.1.11","article-title":"Regulation of vitamin D action","volume":"14","author":"Brown","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"2021040806375890600_R52","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ki.1993.83","article-title":"Differential effects of 1,25-(OH)2D3 and 22-oxacalcitriol on phosphate and calcium metabolism","volume":"43","author":"Finch","year":"1993","journal-title":"Kidney Int"},{"key":"2021040806375890600_R53","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/ki.1993.280","article-title":"Effect of 22-oxacalcitriol on calcium metabolism in rats with severe hyperparathyroidism","volume":"44","author":"Kubrusly","year":"1993","journal-title":"Kidney Int"},{"key":"2021040806375890600_R54","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1172\/JCI114229","article-title":"The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion","volume":"84","author":"Brown","year":"1989","journal-title":"J Clin Invest"},{"key":"2021040806375890600_R55","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/ki.1991.110","article-title":"Regulation of parathyroid hormone synthesis in chronic renal failure in rats","volume":"39","author":"Fukagawa","year":"1991","journal-title":"Kidney Int"},{"key":"2021040806375890600_R56","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF00582166","article-title":"The effect of a new vitamin D analog, 22-oxa-1\u03b1,25(OH)2D3, on bone mineral metabolism in normal male rats","volume":"50","author":"Takizawa","year":"1992","journal-title":"Calcif Tissue Int."},{"key":"2021040806375890600_R57","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1046\/j.1523-1755.1999.00772.x","article-title":"22-Oxacalcitriol ameliorates high-turnover bone and marked osteitis fibrosa in rats with slowly progressive nephritis","volume":"56","author":"Hirata","year":"1999","journal-title":"Kidney Int"},{"key":"2021040806375890600_R58","first-page":"E141","article-title":"Comparison of 22-oxacalcitriol and 1,25(OH)2D3 on bone metabolism in young X-linked hypophosphatemic male mice","volume":"270","author":"Halstead","year":"1996","journal-title":"Am J Physiol"},{"key":"2021040806375890600_R59","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1046\/j.1523-1755.1999.055003821.x","article-title":"22-Oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure","volume":"55","author":"Monier-Faugere","year":"1999","journal-title":"Kidney Int"},{"issue":"Suppl 3","key":"2021040806375890600_R60","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ndt\/11.supp3.121","article-title":"Effect of 22-oxacalcitriol on hyperparathyroidism of dialysis patients: results of a preliminary study","volume":"11","author":"Kurokawa","year":"1996","journal-title":"Nephrol Dial Transplant."},{"key":"2021040806375890600_R61","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0272-6386(00)70198-3","article-title":"Effect of 22-oxacalcitriol on bone histology of hemodialyzed patients with severe secondary hyperparathyroidism","volume":"35","author":"Tsukamoto","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"2021040806375890600_R62","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.V981427","article-title":"19-Nor-1\u03b1-25-dihydroxyvitamin D2 (paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis","volume":"9","author":"Martin","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"2021040806375890600_R63","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/oxfordjournals.ndt.a027089","article-title":"PTH\/PTHrP receptor mRNA is down-regulated in epiphyseal cartilage growth plate of uraemic rats","volume":"11","author":"Urena","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"2021040806375890600_R64","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1210\/jcem-73-3-516","article-title":"Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients","volume":"73","author":"Solal","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2021040806375890600_R65","first-page":"145","article-title":"Intact parathyroid hormone overestimates the presence and severity of parathyroidmediated osseous abnormalities in uremia","volume":"75","author":"Quarles","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl","key":"2021040806375890600_R66","first-page":"S114","article-title":"Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia, and hyperparathyroidism in uremia","volume":"18","author":"Fournier","year":"1986","journal-title":"Kidney Int"},{"key":"2021040806375890600_R67","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1093\/ndt\/10.12.2228","article-title":"Low-dose calcitriol prevents the rise in 1,84-iPTH without affecting serum calcium and phosphate in patients with moderate renal failure (prospective placebo-controlled multicentre trial)","volume":"10","author":"Ritz","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"2021040806375890600_R68","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1681\/ASN.V251014","article-title":"The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients","volume":"2","author":"Rodriguez","year":"1991","journal-title":"J Am Soc Nephrol"},{"key":"2021040806375890600_R69","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/0140-6736(91)91429-X","article-title":"Is intermittent oral calcitriol safe and effective in renal secondary hyperparathyroidism?","volume":"337","author":"Klaus","year":"1991","journal-title":"Lancet"},{"key":"2021040806375890600_R70","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/ndt\/14.9.2085","article-title":"Hyperphosphataemia\u2014a silent killer of patients with renal failure?","volume":"14","author":"Amann","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"2021040806375890600_R71","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/ki.1993.92","article-title":"Calcium kinetics and the long-term effects of lowering dialysate calcium concentration","volume":"43","author":"Argiles","year":"1993","journal-title":"Kidney Int"},{"issue":"Suppl","key":"2021040806375890600_R72","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1046\/j.1523-1755.1999.07311.x","article-title":"Phosphate binders on iron basis: a new perspective?","volume":"73","author":"Hergesell","year":"1999","journal-title":"Kidney Int"},{"key":"2021040806375890600_R73","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1046\/j.1523-1755.1998.00875.x","article-title":"Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis","volume":"53","author":"Mucsi","year":"1998","journal-title":"Kidney Int"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/15\/suppl_5\/18\/36974792\/1505s0018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/15\/suppl_5\/18\/36974792\/1505s0018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T17:38:47Z","timestamp":1621273127000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/15\/suppl_5\/18\/1838390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10,2]]},"references-count":73,"journal-issue":{"issue":"suppl_5","published-online":{"date-parts":[[2000,10,2]]},"published-print":{"date-parts":[[2000,10,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/15.suppl_5.18","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2000,10,2]]},"published":{"date-parts":[[2000,10,2]]}}}